Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 10001-10050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06847633
A Digital Lifestyle Intervention in Primary Healthcare to Prevent Cardiovascular Disease
NARecruiting
1,000 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2027
2 conditions2 sponsors6 locations
NCT06830044
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
PHASE3Recruiting
500 participants
Started: Mar 3, 2025 · Completed: Mar 31, 2028
1 condition1 sponsor2 locations
NCT06566430
PrEP My Way: a Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women
NARecruiting
500 participants
Started: Mar 3, 2025 · Completed: Dec 1, 2028
1 condition5 sponsors1 location
NCT05931289
Suicide Risk Interventions
PHASE2Recruiting
136 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06880419
Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model
PHASE2Recruiting
174 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06799611
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
PHASE2Recruiting
20 participants
Started: Mar 3, 2025 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT06581874
Evaluation of a Collaborative Mental Health Care System
NARecruiting
478 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT06567054
Clinical Study to Predict the Risk of Bone Fractures With the POROUS Ultrasound Device
NARecruiting
1,600 participants
Started: Mar 3, 2025 · Completed: Aug 31, 2029
3 conditions2 sponsors6 locations
NCT06680622
Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy
PHASE2Recruiting
126 participants
Started: Mar 3, 2025 · Completed: Mar 31, 2028
1 condition4 sponsors35 locations
NCT06607432
Temporal Interference Stimulation for Social Cognition
NARecruiting
30 participants
Started: Mar 3, 2025 · Completed: Feb 29, 2028
1 condition2 sponsors1 location
NCT06646562
Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.
PHASE4Recruiting
120 participants
Started: Mar 3, 2025 · Completed: Jan 30, 2027
1 condition2 sponsors8 locations
NCT07176013
Immersive Virtual Reality Meditation in Voice Therapy
NARecruiting
40 participants
Started: Mar 3, 2025 · Completed: Dec 6, 2026
1 condition1 sponsor1 location
NCT06804941
Transdiagnostic Online CBT Vs. Care As Usual for Primary Care Patients with Common Mental Disorders
NARecruiting
500 participants
Started: Mar 3, 2025 · Completed: Jan 25, 2029
1 condition2 sponsors1 location
NCT06831916
Impact of Cannabinoids on Menopause Symptoms
PHASE2Recruiting
100 participants
Started: Mar 3, 2025 · Completed: Jan 12, 2027
2 conditions2 sponsors1 location
NCT06560762
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
PHASE1Recruiting
12 participants
Started: Mar 3, 2025 · Completed: Dec 15, 2025
1 condition1 sponsor2 locations
NCT06863090
In Vivo Dosimetry for Brachytherapy Study
N/ARecruiting
20 participants
Started: Mar 3, 2025 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location
NCT06950099
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
N/ARecruiting
30 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06936553
Comparison of IL-8, FGF-1 and VEGF Levels in Pulpal Tissue, GCF and Dentinal Fluid Samples of Healthy, Reversible and Irreversible Pulpitis Diagnosed Teeth
N/ARecruiting
50 participants
Started: Mar 3, 2025 · Completed: Dec 3, 2025
5 conditions1 sponsor1 location
NCT06751069
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
NARecruiting
460 participants
Started: Mar 3, 2025 · Completed: Sep 30, 2030
2 conditions2 sponsors3 locations
NCT06871085
Novel Sock Design on Ankle and Postural Stability
NARecruiting
30 participants
Started: Mar 3, 2025 · Completed: Feb 2, 2026
2 conditions1 sponsor1 location
NCT06871098
Improving Mechanics and Confidence in the Hip Hinge
NARecruiting
30 participants
Started: Mar 3, 2025 · Completed: Mar 23, 2026
2 conditions1 sponsor1 location
NCT06613217
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
PHASE1Recruiting
35 participants
Started: Mar 3, 2025 · Completed: Sep 1, 2026
1 condition3 sponsors1 location
NCT06677320
Establishing Clinical Significance in Rotator Cuff Disease
N/ARecruiting
69 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06875622
Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
NARecruiting
490 participants
Started: Mar 3, 2025 · Completed: Oct 31, 2028
1 condition2 sponsors1 location
NCT06744387
Anterolateral Tigh (ALT) Flaps Oxygenation Monitoring by NIRS
N/ARecruiting
20 participants
Started: Mar 3, 2025 · Completed: Dec 30, 2026
4 conditions1 sponsor1 location
NCT06758375
Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients
PHASE2Recruiting
10 participants
Started: Mar 3, 2025 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06880978
Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions
N/ARecruiting
400 participants
Started: Mar 3, 2025 · Completed: Aug 1, 2026
5 conditions12 sponsors1 location
NCT06742892
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
PHASE2Recruiting
90 participants
Started: Mar 3, 2025 · Completed: Jun 5, 2027
1 condition1 sponsor1 location
NCT06888336
Yoga Nidra for Insomnia and Posttraumatic Stress Symptoms
NARecruiting
60 participants
Started: Mar 3, 2025 · Completed: Nov 30, 2025
4 conditions2 sponsors1 location
NCT06996340
White Noise and In-vitro Fertilizasyon
NARecruiting
94 participants
Started: Mar 3, 2025 · Completed: Jun 15, 2025
1 condition2 sponsors1 location
NCT07169500
Autologous Transplantation Combined With BCMA CAR-T in the Treatment of Young NDMM
PHASE1/PHASE2Recruiting
50 participants
Started: Mar 3, 2025 · Completed: Mar 2, 2030
1 condition2 sponsors1 location
NCT06748937
A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide
PHASE2Recruiting
60 participants
Started: Mar 3, 2025 · Completed: Mar 30, 2026
1 condition2 sponsors1 location
NCT06838949
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
PHASE2Recruiting
80 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06222489
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
PHASE2Recruiting
16 participants
Started: Mar 3, 2025 · Completed: May 1, 2028
3 conditions2 sponsors1 location
NCT06827977
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
PHASE2Recruiting
21 participants
Started: Mar 3, 2025 · Completed: Sep 26, 2026
2 conditions1 sponsor1 location
NCT06831123
Pathways 2 Success
PHASE1/PHASE2Recruiting
120 participants
Started: Mar 3, 2025 · Completed: Mar 31, 2027
2 conditions1 sponsor1 location
NCT06874621
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
PHASE1/PHASE2Recruiting
52 participants
Started: Mar 3, 2025 · Completed: May 31, 2027
1 condition1 sponsor23 locations
NCT06863233
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer
PHASE1Recruiting
5 participants
Started: Mar 3, 2025 · Completed: Mar 3, 2028
3 conditions1 sponsor7 locations
NCT07105163
Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis
N/ARecruiting
480 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT06882057
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
PHASE2/PHASE3Recruiting
3,000 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2033
3 conditions1 sponsor27 locations
NCT06936930
Reproductive and Mental Health of Patients With Aplastic Anemia
N/ARecruiting
600 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06848400
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
NARecruiting
482 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2026
6 conditions12 sponsors12 locations
NCT06845202
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
PHASE1/PHASE2Recruiting
144 participants
Started: Mar 3, 2025 · Completed: Aug 31, 2027
2 conditions1 sponsor18 locations
NCT06501053
Contact Radiotherapy for Rectal Cancer
NARecruiting
110 participants
Started: Mar 3, 2025 · Completed: Nov 30, 2032
1 condition3 sponsors2 locations
NCT06760663
The Load-velocity Relationship: Neuromuscular Adaptations to Resistance Training
NARecruiting
30 participants
Started: Mar 3, 2025 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT06937450
Traumatic Hemothorax Drainage and Daily Lavage: Pilot Study
NARecruiting
20 participants
Started: Mar 3, 2025 · Completed: Aug 1, 2027
1 condition2 sponsors1 location
NCT06518057
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
PHASE2Recruiting
22 participants
Started: Mar 3, 2025 · Completed: Jun 30, 2027
5 conditions1 sponsor1 location
NCT06338267
Validating Innovative Biosensors for Rett Autonomic Symptom Tracking
N/ARecruiting
30 participants
Started: Mar 3, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06841055
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following Chemoimmunotherapy
PHASE2Recruiting
60 participants
Started: Mar 3, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor12 locations
NCT06762054
Investigating the Optimal Management of Dolutegravir Resistance
N/ARecruiting
6,600 participants
Started: Mar 3, 2025 · Completed: Oct 31, 2026
1 condition5 sponsors9 locations